Posts tagged with Pharma

allergan

Allergan Facebook initiative shows the risks of social media for pharma marketers

To help reinvigorate sales of its 13 year-old dry eye treatment Restasis in the face of competition from a new drug, pharma giant Allergan turned to the world's largest social network, Facebook.

The company, with the help of its agencies, launched a Facebook Page. According to Fierce Pharma, the effort has largely been a success. 

0 comments
proteus

10 examples of the Internet of Things in healthcare

The next decade may well see a revolution in treatment and diagnosis of disease, as the Internet of Things (IoT) is brought to bear on medicine.

Here are 10 examples of IoT in healthcare.

4 comments
drugs

Six ways digital is changing the pharma & healthcare industry

The pharmaceutical and healthcare industry is rapidly coming to terms with digital technology.

New tech companies are entering the market and existing players have had to up their game, across marketing, sales and operations. If you're relatively new to pharma, like me, here's a summary of just some of the biggest trends.

2 comments

Why Pharma marketers are increasingly turning to social media

It wasn’t long ago that pharma brands tended to avoid social media.

The strict regulation of the industry’s advertising communication still acts as a motivator for the industry to be cautious with social content, yet increasing numbers of brands are taking to social media anyway.

What’s changed?

0 comments

Electronic Health Records (EHRs) could help pharma marketers reach doctors

Pharma companies face a number of challenges when it comes to digital marketing.

We recently reported on the spectre of a consumer marketing clampdown, and how pharma brands aren't making the most of mobile and social opportunities.

3 comments

Millennials open to pharma ads, but pharma not delivering on UX

They're often claimed to be one of the hardest groups to advertise to, but according to the sixth annual Makovsky/Kelton Pulse of Online Search survey, millennials are "by far the most receptive to pharmaceutical marketing."

How receptive? According to the survey (PDF), which polled more than 1,000 Americans over the age of 18, 51% of millennials indicated that they would be motivated by a digital, television or print ad to visit a pharma-sponsored website.

0 comments

Ban on consumer ads could make pharma's digital shortcomings more costly

The American Medical Association (AMA), a powerful lobby that represents more than 200,000 doctors and medical students in the United States, is calling for a ban on direct-to-consumer ads that pitch prescription drugs and medical devices. 

Noting that the US is one of only two countries in the world that allow such ads, the AMA says that "direct-to-consumer advertising...inflates demand for new and more expensive drugs, even when these drugs may not be appropriate."

0 comments

Pharma's mobile & social efforts aren't as healthy as they should be

Despite the fact that pharmaceutical companies have more opportunities than ever to reach physicians through digital channels, many are missing the boat on mobile and social.

According to research by Deloitte Consulting and the Gerson Lehrman Group (GLG), mobile apps published by pharma companies for physicians average just 100 to 5,000 installs in the Google Play store compared to 1m to 5m installs for apps targeting physicians published by third parties.

0 comments

How can Pharma organize for agility in the digital age?

As pharma and healthcare companies embrace the need for digital transformation, how can they ensure that they are set up for success?

I was recently invited to speak at a Brand Innovation Summit in Princeton NJ. Senior representatives from a number of large Pharma and healthcare companies attended the session co-hosted by Hale Advisors and eXL Pharma.  

Attendees were looking for answers to key questions such as: “what makes a company nimble and able to embrace digital transformation?” and “What types of organizational structures are best for pharmaceutical and healthcare companies looking to build digital marketing capabilities?” 

1 comment

Finance and pharma in 2013

A strange combination but these are two areas that may see a big change in the upcoming year - especially if they can get away from the stringent regulations they often work under.

I think marketers working under these conditions have done amazing things and those working in these sectors only have room to grow.

1 comment

Growing pains: Pfizer tackles social media

The minute we’re born, we begin to age. This was apparently the number one concern occupying respondents of a 2011 Gallup survey commissioned by pharma giant Pfizer and the finding upon which the company has based its Get Old social media campaign.

In a press release announcing the multi-year initiative that began last month, Pfizer tied it to the company’s larger mission of improving the health of all people at every stage of life.

PR platitudes aside, the initiative also marks Pfizer’s lengthening social media shadow, cast, in part, by CEO Ian Read, who has criticized the industry for being “slow to adapt” to today’s more open society. Pharma’s hesitation no doubt informs Edelman’s 2011 Trust Barometer, which found public confidence in businesses, governments, and, in a new development, NGOs slipping at a noticeable rate.

When that focus was narrowed to Pfizer alone, the results were no better: About 45 percent of respondents described the drugmaker as unethical and not credible. Not acceptable, according to Read.

0 comments

FDA Social Media Hearings #FDASM

The pharmaceutical industry is glued on the FDA hearings on social media happening in the US. The Food and Drug Administration (FDA) is a government agency of the US Department of Health & Human Sciences and acts as the main regulator of US market for drugs, worth $275 billion-a-year.

2 comments